Kristina Perry, based in Watertown, Massachusetts, United States, is currently a Sr Scientific Advisor, Oncology Biomarkers at Q2 Solutions, bringing experience from previous roles at Alnylam Pharmaceuticals, Amgen, Millennium Pharmaceuticals and Brigham and Women's Hospital. Kristina Perry holds a 2006 - 2012 Doctor of Philosophy (PhD) in Pathology @ Boston University School of Medicine. With a robust skill set that includes Clinical Pathology, Immunohistochemistry, Molecular Pathology, Pathology, Histopathology and more, Kristina Perry contributes valuable insights to the industry. Kristina Perry has 1 email on RocketReach.